Five years after COVID-19 reached pandemic status, public health experts reflect on what we learned—and how those lessons can ...

CoreWeave's IPO priced lower than expected, at $40 per share, raising $1.5B and valuing it at $19B - SiliconANGLE ...

The global Smart Pills Market ,valued at US$0.61 billion in 2023, is forecasted to grow at a robust CAGR of 11.2%, reaching US$0.69 billion ...

A small group of Mayne Pharma holders reckons US bidder Cosette's $600 million tilt does not capture the upside of ... Read ...

We recently published a list of the 12 Best Diagnostics Stocks to Invest In Right Now. In this article, we are going to take a look at where Charles River Laboratories International, Inc.

Discover the top 3 undervalued Commercial Services & Supplies stocks for Monday, March 24 based on AAII’s Stock Grades.

Find insight on Novo Nordisk, Centessa Pharmaceuticals and more in the latest Market Talks covering Health Care.

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET. 0646 ET – Indian shares ended flat, as gains in finance ...

Not all corners of the market are moving in the same direction this year; 2025 has already delivered a few surprises for ...

Staffing shortages, rising costs, efforts to reduce administrative burden on clinicians and other factors are leading many ...

U.S. stock indices slump amid tariff talks while healthcare sees major developments: J&J faces a $1.6B lawsuit, new FDA approvals, and a $2B ...

Health-care companies fell, but not by as much as the broad market, amid a rotation into defensive sectors. Shares of obesity-drug makers and biotech firms, which are engaged in higher-risk activities ...